Biomed & Biotech Firms - Publicly Traded*

Somaxon Pharmaceuticals Inc.

Company Website

3721 Valley Centre Drive, Suite 500
San Diego, CA 92130

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

Somaxon Pharmaceuticals Inc.

Market Cap as of 6/12/2015

Market Cap as of 7/03/2014

Market Cap as of 07/02/2013

Market Cap as of 06/26/2012

$12,508,144

Market Cap as of 01/04/2012

$23,032,760

Market Cap as of 06/20/2011

$94,960,530

Market Cap as of 01/06/2011

$150,787,500

Exchange and Ticker Symbol

Nasdaq: SOMX

Fields of Research

Engages in the in-licensing, development, and commercialization of proprietary branded products and late-stage product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology

Major Products

Silenor

Executives

Richard Pascoe (profile)

  • Chief Executive Officer
  • President

David Hale

  • Executive Chairman